sphingosine-1-phosphate receptor 2 antagonist
Any sphingosine-1-phosphate receptor (S1PR) antagonist that acts as an antagonist for the subtype 2 receptors (S1PR2).
osteogenesis regulator
Any compound that induces or regulates osteogenesis.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
pro-angiogenic agent
Any compound that promotes the growth of new blood vessels from pre-existing vessels.
anti-asthmatic agent
Any compound that has anti-asthmatic effects.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide
|
1-(2,6-dichloro-4-pyridinyl)-3-[(1,3-dimethyl-4-propan-2-yl-6-pyrazolo[3,4-b]pyridinyl)amino]urea
|
ChEBI
|
1-[1,3-dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(2,6-dichloro-4-pyridinyl)-semicarbazide
|
ChEBI
|
JTE 013
|
SUBMITTER
|
JTE013
|
ChEBI
|
N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazine-1-carboxamide
|
IUPAC
|